5/9
07:06 am
qttb
Q32 Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Low
Report
Q32 Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
5/9
06:59 am
qttb
Q32 Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
Low
Report
Q32 Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
4/23
07:04 am
qttb
Seamless Therapeutics Announces New CEO and Board Chairman to Support US Expansion of Programmable Recombinase Gene Editing Technology Platform [Yahoo! Finance]
Low
Report
Seamless Therapeutics Announces New CEO and Board Chairman to Support US Expansion of Programmable Recombinase Gene Editing Technology Platform [Yahoo! Finance]
4/17
08:10 am
qttb
Sensorium Therapeutics Appoints Sam Rasty as Chief Business Officer [Yahoo! Finance]
Medium
Report
Sensorium Therapeutics Appoints Sam Rasty as Chief Business Officer [Yahoo! Finance]
4/11
08:00 am
qttb
Q32 Bio Inc. (NASDAQ: QTTB) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $50.00 price target on the stock.
High
Report
Q32 Bio Inc. (NASDAQ: QTTB) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $50.00 price target on the stock.
4/3
07:00 am
qttb
Q32 Bio Appoints Lee Kalowski as President & Chief Financial Officer
Medium
Report
Q32 Bio Appoints Lee Kalowski as President & Chief Financial Officer
4/2
08:10 am
qttb
Q32 Bio Inc. (NASDAQ: QTTB) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $45.00 price target on the stock.
High
Report
Q32 Bio Inc. (NASDAQ: QTTB) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $45.00 price target on the stock.
3/25
04:15 pm
qttb
Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million
Low
Report
Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million